Atos: contract to reinforce a supercomputer in Sweden | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-11 | 2024-09 | -0.05 | N/A | N/A | N/A |
2024-08-12 | 2024-06 | -0.05 | -0.05 | N/A | N/A |
2024-05-13 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-04-01 | 2023-12 | -0.05 | -0.06 | -0.01 | -20.00% |
2023-11-13 | 2023-09 | 0 | -0.05 | N/A | N/A |
2023-08-14 | 2023-06 | 0 | -0.06 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-07 | Cantor Fitzgerald | Upgrade | Overweight | |
2020-09-16 | Ascendiant Capital | Upgrade | Buy | |
2019-12-17 | Maxim Group | Upgrade | Hold | Buy |
2018-01-25 | Maxim Group | Upgrade | Buy | |
2013-10-06 | Sidoti & Co. | Downgrade | Buy | Neutral |
2013-04-14 | Sidoti & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2016-03-08 | CHEN SHU-CHIH | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2013-05-14 | CROSS ALEXANDER DENNIS | Director | 0.00 | Purchase |
2024-04-09 | FINN JONATHAN F. | Director | 25.00K | Purchase |
2017-11-14 | GUSE KYLE | General Counsel | 10.00K | Purchase |
2016-03-08 | QUAY STEVEN C | Chief Executive Officer | 0.00 | Purchase |
2017-04-16 | REMMEL H LAWRENCE | Director | 3.13K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 5.68M | 7.15M | 4.51% |
2023-06-29 | Blackrock Inc. | 2.90M | 3.65M | 2.30% |
2023-06-29 | Laurion Capital Management, LP | 2.23M | 2.80M | 1.77% |
2023-06-29 | Geode Capital Management, LLC | 1.11M | 1.40M | 0.88% |
2023-06-29 | Renaissance Technologies, LLC | 1.07M | 1.35M | 0.85% |
2023-06-29 | State Street Corporation | 436.27K | 549.70K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.78M | 4.76M | 3.00% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.66M | 2.10M | 1.32% |
2023-05-30 | Fidelity Extended Market Index Fund | 659.95K | 613.75K | 0.52% |
2023-05-30 | BlackRock Advantage Small Cap Core Fund | 340.50K | 316.67K | 0.27% |
2023-05-30 | Fidelity Total Market Index Fund | 182.91K | 170.11K | 0.15% |
2023-05-30 | Fidelity Series Total Market Index Fund | 142.17K | 132.22K | 0.11% |
Split | Date |
---|---|
1 : 12 | 2018-04-20 |
1 : 15 | 2016-08-26 |
-
Stop crying TOM JAMES. You 200 shares are safe
-
ATOSSA has an active FaceBook page
-
2.75 tomorrow.
-
Sold twice today and rebought absolute gifts. 8k at 3.22 and rebought them all at 3.05. Screw waiting on these fools to update, too easy to just trade these dips.
-
866-893-4927 ATOSSA THERAPEUTICS
-
See the ones complaining about others selling? Those are your fake “paper hands” Longs. They always out themselves.
-
Nice position Chris
-
Because some of us actually swing our shares to make actual money, Jerry. You keep clutching those 500 shares and praying for $6 though.
-
It’s why they are a buyout candidate. They have promising products, but management lacks the ability to properly develop it and take it to market. PR is non-existent, they don’t understand how to properly utilize dropping news at the appropriate times. They could have raised all the capital they needed had they done it correctly, instead they try to force a vote for dilution through and got a resounding NO from shareholders. Why? Because you gave them nothing to sway their opinion. Still no update after it being promised months ago.
Hopefully big pharma with solid development
team buys this out. Ton of potential, just needs guidance. 26k shares, Holding 10k shares back in case of news, swinging the other 16k. Could blow up today or could be 6 months down the road.swinging 16k of them every chance I get. Anything can happen at any time.
-
Either way I’ll swing half my shares. Shitty management with no PR just means this will not runup much.
-
All Quay has to do is release the updates that was promised over a month ago. Only one reason to drag ass and that’s if the results aren’t good.
-
What do you expect, great potential products, shitty management.
-
Sold at 3.24 and rebought at 3.14 $1400 in two days just selling and buying the dip that happens every morning. Should have been doing this all along.
-
Headed to red. No trial results, nothing to prop it up.
-
Please stfu about Shorts being in trouble. Y’all look dumber every damn day with this bullshit. I’m bullish on this but some of y’all are straight up dumb when it comes to knowing the market and the process.
-
Wtf y’all keep worrying about Shorts? They gonna do what they gonna do.
-
Because they never reach potential lol. Quay prefers to chase conspiracy theories instead of releasing trial updates.
-
Please let this get bought out by someone with a competent PR dept.
-
Watch Quay get suicided and everything collapses
-
company just refuses to give results updates. At this point I’m starting to suspect they aren’t very positive.
-
Atos: contract to reinforce a supercomputer in Sweden
news.google.com •